Robert Maximos, MD
Pulmonary Disease · Beverly, MANPI 1962732040
Payments from drug & device makers
Across 26 payments — averaging $266.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- Pinnacle Biologics, Inc$2K
- Noah Medical Corporation$461
- Pulmonx Corporation$343
- Medtronic$192
- AstraZeneca$124
- plus $36 from 2 others
What the payments were for
- Consulting fees$4006%
- Speaking & faculty fees$1,00014%
- Travel & lodging$1,50722%
- Food & beverage$1,02915%
- Education$3,00043%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 5 | $3,703 |
| Pinnacle Biologics, Inc | 9 | $2,076 |
| Noah Medical Corporation | 3 | $461 |
| Pulmonx Corporation | 4 | $343 |
| Medtronic | 2 | $192 |
| AstraZeneca | 1 | $124 |
| AbbVie | 1 | $25 |
| Veran Medical Technologies, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ION$3,000
- Photofrin$1,719
- Da Vinci Surgical System$661
- GALAXY$400
- CHARTIS CATHETER$252
- ZEPHYR DELIVERY CATHETER$252
- ZEPHYR ENDOBRONCHIAL VALVE$252
- PULMONX CHARTIS TABLET CONSOLE$252
- Signia$142
- FASENRA$124
How this compares
$6,936 in reported general payments places this provider in the 75th percentile of 482 pulmonary disease providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $505 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Beverly
- Lee GazourianBeverly$239K
- Aaron WaxmanBoston$7.7M
- John BerkBoston$6M
- Darrell KottonBoston$5.3M
- Hilary GoldbergBoston$3.5M
- Ehab BillatosWinchester$2.7M
- Harrison FarberBoston$2.6M
- Elizabeth KlingsBoston$2.1M
- Curtis MelloNorth Dartmouth$1.9M
- Gary HunninghakeBoston$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.